LobbyingOno Pharmaceutical lobbying by quarter
Ono Pharmaceutical's latest lobbying report covers Q2 2026, at $50K. The four quarters Q3 2025–Q2 2026 total $265K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Ono Pharmaceutical
- Latest quarter
- $50K
- Q2 2026 · 1 reports
- Last 12 months
- $265K
- Last 4 quarters
- vs last quarter
- +900.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $110K | 1 |
| Q4 2025 | $100K | 1 |
| Q1 2026 | $5,000 | 1 |
| Q2 2026 | $50K | 1 |
Policy issues the reports name
- Health issues4 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
- Food & Drug Administration (FDA)3 reports
- Health & Human Services, Dept of (HHS)3 reports
Firms it paid
| Firm | ||
|---|---|---|
| Greenberg Traurig | $265K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLES F. BASS | U.S. Congressman (97 - 07) & (11 - 13) | Q2 2026 |
| RODNEY FRELINGHUYSEN | U.S. Congressman (1995 - 2019) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Greenberg Traurig | $50K |
| 04/20for Q1 | Greenberg Traurig | $5,000 |
| 01/16for Q4 2025 | Greenberg Traurig | $100K |
| 25/10/20for Q3 2025 | Greenberg Traurig | $110K |
| 25/09/15for Q3 2025 | Greenberg Traurig | Under $5,000 |
| 25/07/18for Q2 2025 | Greenberg Traurig | Under $5,000 |
| 25/04/17for Q1 2025 | Greenberg Traurig | Under $5,000 |
| 25/01/17for Q4 2024 | Greenberg Traurig | Under $5,000 |
| 24/10/21for Q3 2024 | Greenberg Traurig | Under $5,000 |
| 24/07/22for Q2 2024 | Greenberg Traurig | Under $5,000 |
| 24/04/22for Q1 2024 | Greenberg Traurig | Under $5,000 |
| 24/01/22for Q4 2023 | Greenberg Traurig | Under $5,000 |
| 23/10/20for Q3 2023 | Greenberg Traurig | Under $5,000 |
| 23/07/20for Q2 2023 | Greenberg Traurig | Under $5,000 |
| 23/04/20for Q1 2023 | Greenberg Traurig | Under $5,000 |
| 23/01/20for Q4 2022 | Greenberg Traurig | Under $5,000 |